How does psoriasis prevalence differ in cold climates, what percentage of populations report flare-ups, and how do outcomes compare with warm-climate populations?

Psoriasis prevalence is significantly higher in cold climates, with a distinct “latitude gradient” where the disease becomes more common the further a population is from the equator. A very high proportion of patients in these regions, with many studies suggesting between 50% and 80%, report seasonal flare-ups, particularly during the winter months. Consequently, outcomes for psoriasis patients in cold climates are generally poorer compared to those in warm-climate populations, with individuals often experiencing more severe disease, a greater negative impact on quality of life, and a higher treatment burden.

The Latitude Effect: How Climate Shapes Psoriasis Across the Globe ☀️❄️

Psoriasis is a complex chronic autoimmune disease, a story written in an individual’s genes but edited by their environment. While genetic predisposition lays the groundwork, environmental triggers are the powerful editors that determine when the story begins and how it unfolds. Among the most influential of these factors is climate. The difference between living with psoriasis in the sun-drenched tropics versus the long, dark winters of the north is so profound that it impacts everything from the likelihood of developing the disease in the first place to its severity and the very nature of its treatment.

The Geographic Divide: Why Psoriasis Prevalence Rises with Latitude

One of the most striking observations in psoriasis epidemiology is the “latitude gradient.” There is a clear and well-documented trend: the prevalence of psoriasis increases in populations living further away from the equator.

In equatorial regions, such as parts of Southeast Asia, Africa, and South America, psoriasis is relatively rare, with prevalence rates often falling below 0.5%.
As you move into subtropical and temperate zones, like the southern United States or Mediterranean Europe, the rates increase, typically to around 2-3%, which is the commonly cited average for Western populations.
In the high-latitude countries of Northern Europe, particularly Scandinavia, the prevalence reaches its peak. In Norway, for example, studies have reported a staggering prevalence of up to 11.4%, one of the highest in the world.

This geographic pattern is not a coincidence. It is primarily attributed to one critical environmental factor: sunlight, specifically ultraviolet B (UVB) radiation.

The Power of UVB Light: Sunlight is nature’s most potent immunosuppressant for the skin. UVB radiation works to control psoriasis in two main ways:

Slowing Skin Cell Growth: In psoriasis, the immune system mistakenly signals skin cells (keratinocytes) to grow and multiply at an accelerated rate, leading to the formation of thick plaques. UVB light penetrates the skin and directly slows down this hyperproliferation.
Suppressing the Skin’s Immune Response: UVB has a powerful localized immunomodulatory effect. It dampens the activity of the overactive T-cells and reduces the production of the inflammatory cytokines (like TNF-alpha and IL-17) that drive the psoriatic process.

This is the principle behind medical phototherapy, a highly effective treatment for psoriasis. People living in warm, sunny climates receive a consistent, low dose of this natural therapy year-round, which is thought to suppress the manifestation of the disease in genetically predisposed individuals, leading to lower overall prevalence.

The Vitamin D Hypothesis: Closely linked to sunlight is Vitamin D. The skin synthesizes Vitamin D when exposed to UVB radiation. Vitamin D is not just for bone health; it is a crucial regulator of the immune system and skin cell growth. The lower levels of sun exposure in cold climates lead to widespread Vitamin D deficiency, which is thought to be another contributing factor to the higher prevalence of psoriasis in these regions.

The Winter Woe: A Season of Flares

For the millions who already have psoriasis, the arrival of winter is often met with dread. While the disease is chronic, its activity ebbs and flows, and for a vast majority, winter is a season of significant worsening.

What percentage of the population reports flare-ups? While this can vary by region, the numbers are consistently high. Multiple surveys and cohort studies have found that a substantial majority of psoriasis patients experience seasonal worsening. The reported figures typically range from 50% to over 80% of patients identifying winter as the worst season for their skin. This is not a minor inconvenience; it often means a significant increase in itching, scaling, and the appearance of new, painful plaques.

Why is winter so problematic? The winter environment creates a “perfect storm” of triggers that conspire to aggravate psoriasis:

Lack of Sunlight: This is the most obvious factor. The shorter days and weaker sun angle mean dramatically reduced exposure to the beneficial effects of UVB radiation.
Low Humidity and Dry Air: Cold air holds less moisture. When this is combined with the dry heat from indoor central heating systems, the relative humidity plummets. This relentlessly draws moisture from the skin, compromising its barrier function. A dry, damaged skin barrier is more prone to cracking, itching, and inflammation.
The Koebner Phenomenon: This is a specific reaction in psoriasis where new plaques can form at the site of a skin injury, including simple friction or irritation. Heavy, coarse, and multi-layered winter clothing can constantly rub against the skin, potentially triggering new lesions.
Increased Infections: Winter is the peak season for upper respiratory tract infections like the common cold, flu, and streptococcal (strep) throat. These infections can send the immune system into overdrive, which can, in turn, trigger a severe psoriasis flare, particularly a form known as guttate psoriasis.
Psychological Stress and Mood: The “winter blues” or the more severe Seasonal Affective Disorder (SAD) can be significant stressors. There is a well-established link between psychological stress, the body’s stress hormone (cortisol), and the worsening of psoriasis.

A Tale of Two Climates: Comparing Patient Outcomes

The cumulative effect of these climatic differences leads to markedly different outcomes for patients living in cold versus warm regions. “Outcomes” can be measured in terms of disease severity, quality of life, and the required level of treatment.

Feature	Cold Climate Populations (e.g., Scandinavia, Canada)	Warm Climate Populations (e.g., Mediterranean, Southeast Asia)
Psoriasis Prevalence	High (3-11%). A larger portion of the population has the disease.	Low (<1-2%). The disease is less common in the general population.
Main Environmental Triggers	Lack of UV light, low humidity, dry indoor heat, friction from clothing, seasonal infections. 🥶	Sunburn, excessive sweating, and humidity can sometimes trigger inverse (skin fold) psoriasis.
Disease Severity (PASI Score)*	Generally higher. Patients often experience a significant worsening of their disease in the winter, leading to a higher average annual severity.	Generally lower. Consistent sun exposure helps keep the disease milder and more manageable year-round.
Quality of Life (DLQI)**	More significant negative impact. Higher disease severity, combined with the need to cover up and the psychological effects of winter, can lead to a lower quality of life.	Less negative impact. Milder disease and a lifestyle that allows for more skin exposure can lead to better psychological well-being and social functioning.
Treatment Approach	Often requires “stepping up” therapy in winter. Patients may need to switch from topicals to phototherapy or systemic/biologic drugs to control flares.	Often allows for “stepping down” therapy. Patients may be able to manage their condition with less medication, relying more on natural sun exposure.
Key Environmental Factor	Lack of UVB is the primary negative factor.	Abundant UVB is the primary positive, therapeutic factor. ☀️

*PASI (Psoriasis Area and Severity Index) is a clinical score used to measure the severity of psoriasis. A higher score means more severe disease. **DLQI (Dermatology Life Quality Index) is a questionnaire used to measure the impact of a skin condition on a patient’s life. A higher score means a greater negative impact.

Patients in warmer climates often report that their skin naturally improves or even clears during the summer months, allowing them to reduce their reliance on medications. In contrast, patients in colder climates must be incredibly vigilant with their management routines throughout the winter to prevent severe flares, often requiring more potent and costly treatments to maintain control.

Conclusion: Adapting to the Environment

The evidence is overwhelming: climate, and particularly the availability of sunlight, is a major determinant of psoriasis prevalence and severity. The high latitudes of the world present a challenging environment for those with psoriatic disease, leading to a higher prevalence in the population and a cyclical, often severe, pattern of winter flares for those affected. Warm climates, with their year-round supply of natural phototherapy, offer a much more favorable environment, resulting in milder disease and better overall outcomes.

Understanding this dynamic is crucial for patient empowerment. While moving to a warmer climate is not a feasible option for most, patients in colder regions can adopt strategiessuch as diligent moisturizing, using a humidifier, seeking medical phototherapy, and managing stressto proactively combat the winter woe and mitigate the profound impact of their environment on their skin.

Frequently Asked Questions (FAQs) 🤔

1. If I have psoriasis, should I consider moving to a warmer climate? While many people do find their psoriasis improves significantly in a sunny climate, moving is a major life decision with many factors. For some, the benefit is dramatic. For others, it might be less so, as other triggers (like stress) still exist. It’s often recommended to try spending an extended holiday in a warm, sunny location to see how your skin responds before considering a permanent move.

2. Is using a commercial tanning bed a good substitute for sunlight in the winter? No, absolutely not. This is a critical point. Commercial tanning beds emit primarily UVA radiation, which is much less effective for psoriasis than UVB and is strongly linked to an increased risk of melanoma and other skin cancers. Medical phototherapy uses specific, controlled wavelengths of UVB light in a clinical setting, which is a safe and effective treatment. Tanning beds are not a safe alternative.

3. How can I best protect my skin during a cold winter? The key is MOISTURIZE, MOISTURIZE, MOISTURIZE! Apply a thick, fragrance-free cream or ointment to your entire body daily, especially after bathing. Run a humidifier in your home, particularly in the bedroom, to add moisture to the air. Wear soft, layered clothing (like cotton) instead of rough fabrics like wool, and try to avoid overheating.

4. Why does getting sick with the flu seem to make my psoriasis so much worse? Psoriasis is an autoimmune disease. When you get an infection, your immune system ramps up its activity to fight off the invading virus or bacteria. In a person with psoriasis, this heightened state of immune alert can become misdirected, causing the immune cells to also attack the skin, leading to a sudden and often severe flare.

5. Does humidity actually help, or is it just the sun? Humidity plays a very important supportive role. High humidity helps the skin to retain its natural moisture and keeps the skin barrier healthy and intact. A strong skin barrier is less prone to the tiny cracks and irritation that can trigger a psoriatic flare-up. So, while the sun (UVB) is the primary therapeutic factor, the humidity in warm climates provides a constant, soothing “moisturizing” effect that is highly beneficial.

I’m Mr.Hotsia, sharing 30 years of travel experiences with readers worldwide. This review is based on my personal journey and what I’ve learned along the way. Learn more